Ketovate Tablet contains Ketoconazole 200mg, an antifungal agent belonging to the imidazole class, indicated for the treatment of various fungal infections. Ketoconazole exerts its therapeutic effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is commonly prescribed for systemic and superficial mycoses, including candidiasis, dermatophytosis, and pityriasis versicolor. Ketovate Tablet is effective against a broad spectrum of pathogenic fungi such as Candida species, Trichophyton, Microsporum, and Epidermophyton. It is typically administered orally, with dosage and duration tailored according to the severity and type of infection. Patients should adhere strictly to the prescribed regimen to ensure optimal efficacy and minimize the risk of resistance development. Ketovate is contraindicated in individuals with known hypersensitivity to ketoconazole or other azole antifungals. Caution is advised in patients with hepatic impairment due to the potential for hepatotoxicity; liver function tests should be monitored periodically during treatment. Common adverse effects may include gastrointestinal disturbances, headache, and, rarely, hepatotoxicity. Ketovate Tablet should be used under medical supervision, and patients are advised to report any unusual symptoms promptly.